Achieving sustained virological response after direct-acting antiviral therapy reduces liver-related events among those with decompensated HCV cirrhosis.
A local Conservative MLA is calling on BC Transplant and the NDP government to immediately intervene in the case of a Kelowna ...
11d
This woman had to campaign to find a liver donor. Transplant docs say there should be a better way
It's pretty unusual in the medical system for a patient to be tasked with finding their own cure. But that’s what happened to ...
Aldeyra Therapeutics reports positive results from phase 2 clinical trial in alcohol-connected hepatitis: Lexington, Massachusetts Thursday, October 30, 2025, 17:30 Hrs [IST] Alde ...
Clinical Trials Arena on MSN
Aldeyra reshuffles pipeline, culling asset despite Phase II success
Despite ADX-629 meeting all its endpoints in a Phase II trial, Aldeyra is culling the asset as part of a pipeline ...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback